Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pediatrics/Neonatology

Clinical Trials: Phenylketonuria


A listing of clinical trials currently looking for volunteers to enroll in Phenylketonuria studies. Click on the closest city to find more detailed information on a research study in your area.

California

Los Angeles :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Los Angeles :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Orange :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Palo Alto :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

San Diego :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

View More »

San Francisco :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

San Francisco :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Colorado

Aurora :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Aurora :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Florida

Gainesville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Gainesville :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Jacksonville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Miami :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Tampa :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

View More »

Tampa :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Georgia

Decatur :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Decatur :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Illinois

Chicago :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Chicago :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Indiana

Indianapolis :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Iowa

Iowa City :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Kansas

Wichita :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Kentucky

Louisville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Louisiana

New Orleans :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Massachusetts

Boston :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Boston :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Minnesota

Minneapolis :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Missouri

Columbia :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Kansas City :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

St. Louis :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Nebraska

Omaha :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

New York

Albany :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Manhasset :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

New York :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Rochester :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Valhalla :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

North Carolina

Chapel Hill :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Ohio

Akron :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Cincinnati :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Cincinnati :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Cleveland :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Columbus :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Oregon

Portland :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Portland :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Pennsylvania

Hershey :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Hershey :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Philadelphia :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Philadelphia :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Pittsburgh :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

View More »

Pittsburgh :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Rhode Island

Providence :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

South Dakota

Sioux Falls :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Tennessee

Knoxville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Nashville :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Texas

Houston :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Utah

Salt Lake City :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Virginia

Charlottesville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Norfolk :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Wisconsin

Madison :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Milwaukee :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Milwaukee :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Canada

Edmonton :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Halifax :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

London :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Montreal :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Toronto :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

View More »

Vancouver :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Winnipeg :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Norway

Oslo : Department of Paediatric Research, Division of Paediatrics, Oslo University Hospital, Rikshospitalet

Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period

Puerto Rico

San Juan :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

United States

Washington :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Washington DC :

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients